一覧に戻る

タイトル
  • Trend for Clinical Use of Metabolic Associated Fatty Liver Disease (MAFLD)
作成者
    • Bando, Hiroshi
権利情報
  • This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
主題
  • Other Fatty Liver
  • Other Non-Alcoholic Fatty Liver Disease
  • Other Metabolic Associated Fatty Liver Disease
  • Other Non-Alcoholic Steatohepatitis
内容注記
  • Other The problems among obesity, diabetes mellitus (DM), fatty liver, metabolic dysfunction have been prevalent, and diagnostic criteria as non-alcoholic fatty liver disease (NAFLD) has been used in practice. When diagnosing NAFLD, to exclude other related liver diseases was necessary, including excessive alcohol intake. The international experts proposed the proper term from NAFLD to metabolic associated fatty liver disease (MAFLD). MAFLD criteria include the evidence of the presence of hepatic steatosis associated with three situations. They are obesity/overweight, presence of Type 2 DM (T2DM), or metabolic impaired function, which were studied in the light of pathophysiology, epidemiology, diagnosis and pharmacotherapy.
出版者 Asploro
日付
    Issued2021-04-30
言語
  • eng
資源タイプ journal article
出版タイプ VoR
資源識別子 URI http://repo.lib.tokushima-u.ac.jp/115958
関連
  • isIdenticalTo DOI https://doi.org/10.36502/2021/ASJBCCR.6237
収録誌情報
    • ISSN 2582-0370
      • Asploro Journal of Biomedical and Clinical Case Reports
      • 巻4 号2 開始ページ99 終了ページ102
ファイル
コンテンツ更新日時 2023-06-26